Frontlight ResearchEarly access
Trial site
CHRISTUS Saint Patrick Hospital
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Triple-negative breast cancer2 trials
- Phase
- Phase 35 trials
- Status
- Active, not recruiting6 trials
- Lead sponsor
- National Cancer Institute (NCI)4 trials
- ECOG-ACRIN Cancer Research Group1 trial
- NRG Oncology1 trial
Running trials
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026